<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2340-9894</journal-id>
<journal-title><![CDATA[Ars Pharmaceutica (Internet)]]></journal-title>
<abbrev-journal-title><![CDATA[Ars Pharm]]></abbrev-journal-title>
<issn>2340-9894</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2340-98942021000400404</article-id>
<article-id pub-id-type="doi">10.30827/ars.v62i4.21614</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Consecuencias derivadas de la automedicación con benzodiacepinas en personas adultas: revisión exploratoria]]></article-title>
<article-title xml:lang="en"><![CDATA[Consequences derived from self-medication with benzodiazepines in adults: scoping review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cantos-Azorín]]></surname>
<given-names><![CDATA[Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Miguel Hernández Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[Campus Sant Joan d'Alacant Alicante]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Miguel Hernández Departamento de Salud Pública e Historia de la Ciencia ]]></institution>
<addr-line><![CDATA[Campus Sant Joan d'Alacant, Alicante ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto de Salud Carlos III Escuela Nacional de Medicina del Trabajo Área de Divulgación e Investigación y Servicios]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>62</volume>
<numero>4</numero>
<fpage>404</fpage>
<lpage>418</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2340-98942021000400404&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2340-98942021000400404&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2340-98942021000400404&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  Revisar la evidencia científica sobre las consecuencias derivadas de la automedicación con benzodiacepinas (BZD) en personas adultas.  Método:  Revisión exploratoria de los artículos recuperados de las bases de datos MEDLINE (PubMed), Embase, Cochrane Library, Scopus y Web of Science hasta octubre de 2020. La búsqueda se formuló&#769; mediante los descriptores "Self Medication" y "Benzodiazepines", utilizando los Entry Terms relacionados y los filtros: «Humans» y «Adult: 19+years». La calidad de los artículos se evaluó&#769; mediante STROBE.  Resultados:  De las 388 referencias recuperadas, tras aplicar los criterios de inclusión y exclusión, se seleccionaron 14 artículos. Las puntuaciones STROBE oscilaron entre mínimo de 8,7 y máximo de 17,7, con mediana de 14,3. En 8 artículos se estudió la automedicación; en 2 el abuso; en otros 2 la automedicación o el abuso con la finalidad de tratar las emociones, el estrés o, directamente, drogarse. Otros resultados fueron la sobredosificación y el consumo previo y posterior de BZD al ingreso en programa de metadona.  Conclusiones:  Los artículos revisados reportaron elevada prevalencia de automedicación y auto-manipulación de BZD. Es necesario conocer el patrón de uso en cada grupo poblacional para establecer medidas que garanticen una adecuada prescripción y uso racional. Mejorando la atención farmacéutica en el proceso de dispensación de BZD (alertando sobre las consecuencias de un tratamiento crónico y la exclusividad de las recetas) y la validación farmacéutica (detección de prescripciones inadecuadas), se podría actuar contra la automedicación de las BZD y las consecuencias derivadas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  To review the scientific evidence on the consequences of self-medication with benzodiazepines (BZD) in adults.  Method:  Exploratory review of the articles retrieved from the bibliographic databases MEDLINE (PubMed), Embase, Cochrane Library, Scopus and Web of Science until October 2020. The search query was formulated using the descriptors "Self Medication" and "Benzodiazepines", also using the related Entry Terms and filters: «Humans» and «Adult: 19+years». The quality of the articles was evaluated using the STROBE questionnaire.  Results:  From the 388 references retrieved, after applying the inclusion and exclusion criteria, 14 articles were selected. Once the articles were evaluated by means of the STROBE questionnaire for this review the scores ranged from a minimum of 8.7 to a maximum of 17.7, with median equal to 14.3. Self-medication was studied in 8 articles; overuse was researched in 2 of them; 2 other articles' aim was to examine self-medication or overuse with the purpose of treating emotions, stress or, directly, using them as drug. Other observed outcomes were overdosage, in addition to their previous and subsequent consumption to joining the methadone program.  Conclusions: The revised articles have documented a high prevalence of self-medication and self-manipulation of BZD. It is essential to know the use pattern of each population branch in order to establish measures which guarantee both suitable prescription and rational use. By improving pharmaceutical care in the process of dispensing BZD (warning of the effects of chronic treatment and the exclusivity of prescriptions) and pharmaceutical validation (detection of unsuitable prescriptions) BZD self-medication and its derived consequences could be actively prevented.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Automedicación]]></kwd>
<kwd lng="es"><![CDATA[Benzodiazepinas]]></kwd>
<kwd lng="es"><![CDATA[Trastornos Relacionados con Sustancias]]></kwd>
<kwd lng="es"><![CDATA[Programas de Monitoreo de Medicamentos Recetados]]></kwd>
<kwd lng="es"><![CDATA[Medicamentos bajo Prescripción]]></kwd>
<kwd lng="en"><![CDATA[Self Medication]]></kwd>
<kwd lng="en"><![CDATA[Benzodiazepines]]></kwd>
<kwd lng="en"><![CDATA[Substance-Related Disorders]]></kwd>
<kwd lng="en"><![CDATA[Prescription Drug Monitoring Programs]]></kwd>
<kwd lng="en"><![CDATA[Prescription Drugs]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Collares]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ormaechea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso racional de benzodiacepinas: hacia una mejor prescripción]]></article-title>
<source><![CDATA[Rev Urug Med Interna]]></source>
<year>2016</year>
<volume>1</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>14-24</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busto]]></surname>
<given-names><![CDATA[UE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo en el abuso y la dependencia a benzodiacepinas]]></article-title>
<source><![CDATA[Trastor Adict]]></source>
<year>2000</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>177-82</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guina]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Merrill]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives]]></article-title>
<source><![CDATA[J Clin Med]]></source>
<year>2018</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prasad]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Self Medication and their consequences: A challenge to health professional]]></article-title>
<source><![CDATA[Asian J Pharm Clin Res]]></source>
<year>2016</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>314-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Airagnes]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pelissolo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lavallée]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Flament]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Limosin]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management]]></article-title>
<source><![CDATA[Curr Psychiatry Rep]]></source>
<year>2016</year>
<volume>18</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>The United Nations Office on Drugs and Crime</collab>
<source><![CDATA[World Drug Report 2019]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Vienna, Austria ]]></publisher-loc>
<publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Comisión Interamericana para el Control del Abuso de Drogas. Organización de los Estados Americanos</collab>
<source><![CDATA[Informe sobre el Consumo de Drogas en las Américas 2019]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Washington DC, USA ]]></publisher-loc>
<publisher-name><![CDATA[CICAD, OEA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Sánchez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Una adicción invisible: Práctica de prescripción y representaciones sociales del consumo de benzodiazepinas desde el enfoque de género]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Elche, España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Miguel Hernández]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>Agencia Española de Medicamentos y Productos Sanitarios</collab>
<source><![CDATA[Utilización de medicamentos ansiolíticos e hipnóticos en España durante el periodo 2000-2012]]></source>
<year>2014</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad, Servicios Sociales e Igualdad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moher D]]></surname>
<given-names><![CDATA[Altman DG]]></given-names>
</name>
</person-group>
<collab>PRISMA Group</collab>
<article-title xml:lang=""><![CDATA[Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement]]></article-title>
<source><![CDATA[PLoS Med]]></source>
<year>2009</year>
<volume>6</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wanden-Berghe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic reviews in nutrition: standardized methodology]]></article-title>
<source><![CDATA[Br J Nutr]]></source>
<year>2012</year>
<volume>107</volume>
<numero>Suppl 2</numero>
<issue>Suppl 2</issue>
<page-range>S3-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[von Elm]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Altman]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Egger]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pocock]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gøtzsche]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Vandenbroucke]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2008</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>144-50</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berkman]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
<name>
<surname><![CDATA[Lohr]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
<name>
<surname><![CDATA[Ansari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McDonagh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Balk]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Whitlock]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality:An Update]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Research]]></surname>
<given-names><![CDATA[Agency for Healthcare]]></given-names>
</name>
<name>
<surname><![CDATA[Quality]]></surname>
<given-names><![CDATA[(AHRQ)]]></given-names>
</name>
</person-group>
<source><![CDATA[Methods Guide for Effectiveness and Comparative Effectiveness Reviews]]></source>
<year>2008</year>
<publisher-loc><![CDATA[USA ]]></publisher-loc>
<publisher-name><![CDATA[AHRQ]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McCarthy]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sahm]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[J Psychoactive]]></article-title>
<collab>Byrne S "You Don't Feel": The Experience of Youth Benzodiazepine Misuse in Ireland</collab>
<source><![CDATA[Drugs]]></source>
<year>2018</year>
<volume>50</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>121-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio González]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Redondo Martín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hospital Emergencies Associated with the Consumption of Hypnotics and Sedatives, 2009-2013, Castilla y León, Spain]]></article-title>
<collab>Ruíz López Del Prado G.Muñoz Moreno MF.Velázquez Miranda A</collab>
<source><![CDATA[Rev Esp Salud Publica]]></source>
<year>2016</year>
<volume>90</volume>
<page-range>e1-e12</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caro-Mantilla]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Apolinaire-Pennini]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[González-Menéndez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso inadecuado de psicofármacos en las personas de 60 años y más]]></article-title>
<source><![CDATA[Revista Finlay]]></source>
<year>2013</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Forde]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[D'Adamo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Weintraub]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gandhi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine use and misuse among patients in a methadone program]]></article-title>
<source><![CDATA[BMC Psychiatry]]></source>
<year>2011</year>
<volume>11</volume>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Farooq]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pattern of Benzodiazepine use in Nurses]]></article-title>
<source><![CDATA[Gomal J Med Sci]]></source>
<year>2011</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>28-31</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klemenc-Ketis]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Hladnik]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kersnik]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A cross sectional study of sex differences in self-medication practices among university students in Slovenia]]></article-title>
<source><![CDATA[Coll Antropol]]></source>
<year>2011</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>329-34</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
<name>
<surname><![CDATA[Cañas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carlson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Silvestrini]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Corva]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mestorino]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Self-Medication, Substance Abuse and Alcohol Consumption in Students Attending to La Plata National University, Argentina]]></article-title>
<source><![CDATA[Lat Am J Pharm]]></source>
<year>2010</year>
<volume>29</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1425-30</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Divac]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Jasovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Djukic]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Vujnovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Babic]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bajcetic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2004</year>
<volume>13</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>315-22</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva Herrera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vergara Fabián]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yera Alós]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Freijoso]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilización de benzodiazepinas en la Atención Primaria de Salud]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>2002</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segura Noguera]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Barreiro Montaña]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Bastida Bastús]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Collado Gastalver]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[González Solanellas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Linares Juan de Sentmenat]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Home chronic illness and consumption of psychopharmaceuticals]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2000</year>
<volume>26</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>620-3</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gelkopf]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bleich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hayward]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bodner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Adelson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic]]></article-title>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>1999</year>
<volume>55</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>63-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kouyanou]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Pither]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Wessely]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication misuse, abuse and dependence in chronic pain patients]]></article-title>
<source><![CDATA[J Psychosom Res]]></source>
<year>1997</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>497-504</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochs]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Greenblatt]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shader]]></surname>
<given-names><![CDATA[RI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actual versus reported benzodiazepine usage by medical outpatients]]></article-title>
<source><![CDATA[Eur J Clin Pharmacol]]></source>
<year>1987</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>383-8</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ladewig]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abuse of benzodiazepines in western European society--incidence and prevalence, motives, drug acquisition]]></article-title>
<source><![CDATA[Pharmacopsychiatria]]></source>
<year>1983</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>103-6</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bernabeu-Martínez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis bibliométrico y temático de la producción científica existente en la base de datos bibliográfica MEDLINE sobre medicamentos peligrosos en las Unidades de Hospitalización a Domicilio]]></article-title>
<source><![CDATA[Hosp Domic]]></source>
<year>2018</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>101-15</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tomás-Gorriz]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Morales-Suárez-Varela]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio bibliométrico de la producción científica publicada por la revista Ars Pharmaceutica en el periodo 2001 a 2013]]></article-title>
<source><![CDATA[Ars Pharm]]></source>
<year>2014</year>
<volume>55</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urios López]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectos adversos asociados al uso de anabolizantes en deportistas: revisión sistemática]]></article-title>
<source><![CDATA[Ars Pharm]]></source>
<year>2018</year>
<volume>59</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-55</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Macuer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine use in elderly population in Latin America]]></article-title>
<source><![CDATA[Rev Med Chil]]></source>
<year>2017</year>
<volume>145</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>351-9</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-Moya]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez-Pintor]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intervenciones desde la farmacia comunitaria en los pacientes adultos que reciben atención de la salud a domicilio: revisión exploratoria]]></article-title>
<source><![CDATA[Hosp Domic]]></source>
<year>2020</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>209-27</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Troncoso-Piñeiro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[González de Giarratana]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Rivadulla-Lema]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Romero]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neoplasias en trabajadores expuestos al aluminio y/o sus compuestos: Revisión sistemática]]></article-title>
<source><![CDATA[Med Segur Trab]]></source>
<year>2018</year>
<volume>64</volume>
<numero>252</numero>
<issue>252</issue>
<page-range>312-26</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedersen]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Lavik]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adolescents and benzodiazepines: prescribed use, self-medication and intoxication]]></article-title>
<source><![CDATA[Acta Psychiatr Scand]]></source>
<year>1991</year>
<volume>84</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>94-8</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Austic]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein-Ngo]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Veliz]]></surname>
<given-names><![CDATA[PT]]></given-names>
</name>
<name>
<surname><![CDATA[McCabe]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A prospective study of adolescents' nonmedical use of anxiolytic and sleep medication]]></article-title>
<source><![CDATA[Psychol Addict Behav]]></source>
<year>2015</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>184-91</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="book">
<collab>Observatorio Español de las Drogas y las Adicciones</collab>
<source><![CDATA[Informe 2020: Alcohol, tabaco y drogas ilegales en España]]></source>
<year>2020</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klanzler]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Ciraulo]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Zindel]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<source><![CDATA[Clinical Manual of Addiction Psychopharmacology]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Washington DC, USA ]]></publisher-loc>
<publisher-name><![CDATA[American Psychiatric Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maletzky]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Klotter]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Addiction to diazepam]]></article-title>
<source><![CDATA[Int J Addict]]></source>
<year>1976</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>95-115</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Opaleye]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Noto]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[ZM]]></given-names>
</name>
<name>
<surname><![CDATA[Amato]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Locatelli]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Gossop]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nonprescribed use of tranquilizers or sedatives by adolescents: a Brazilian national survey]]></article-title>
<source><![CDATA[BMC Public Health]]></source>
<year>2013</year>
<volume>13</volume>
</nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weaver]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescription Sedative Misuse and Abuse]]></article-title>
<source><![CDATA[Yale J Biol Med]]></source>
<year>2015</year>
<volume>88</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>247-56</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agarwal]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Landon]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patterns in Outpatient Benzodiazepine Prescribing in the United States]]></article-title>
<source><![CDATA[JAMA Netw Open]]></source>
<year>2019</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mathieu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Joly]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Jacqmin-Gadda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wanneveich]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bégaud]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Pariente]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2021</year>
<volume>44</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-62</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baandrup]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ebdrup]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Rasmussen]]></surname>
<given-names><![CDATA[JØ]]></given-names>
</name>
<name>
<surname><![CDATA[Lindschou]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gluud]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Glenthøj]]></surname>
<given-names><![CDATA[BY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2018</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gea Cabrera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Lorente]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[López-Pintor]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Compliance and Adherence to Enteral Nutrition Treatment in Adults: A Systematic Review]]></article-title>
<source><![CDATA[Nutrients]]></source>
<year>2019</year>
<volume>11</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
